• IM Cannabis’ third-quarter 2026 net loss widened 83% year-over-year to C$ 7.08 million.
• Quarterly revenue dropped 68% from a year earlier to C$ 1.65 million.
• For the first nine months of 2026, net loss more than tripled year-over-year to C$ 13.93 million.
• The company completed the sale of its European-focused operations to Slil.com Holding on September 29, retaining its Israeli medical cannabis operations.
• It is negotiating a definitive agreement to acquire a 51% stake in Polish unmanned aerial systems company Space Defense Innovations.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. IM Cannabis Corp. published the original content used to generate this news brief via PR Newswire (Ref. ID: LN97224) on November 13, 2026, and is solely responsible for the information contained therein.